From tens of thousands of rooks in flight to walks along the Taehwagang River, experience nature in the heart of the city this winter
ULSAN, South Korea, Nov. 13, 2026 /PRNewswire/ -- Known for its automotive, shipbuilding and petrochemical industries, Ulsan offers a different view each winter. At dusk, tens of thousands of rooks gather at Samho Bamboo Forest in Nam-gu, forming dark waves against the sunset.
After feeding in nearby fields, the rooks return to the forest to roost. Their aerial displays are one of the "Ulnam Nine Scenic Views," the district's signature sights. In warmer months, herons and egrets nest and raise their young here, making the forest a seasonal home for different migratory birds.
The Taehwagang River also tells the story of Ulsan's ecological recovery. Through restoration and conservation, the once-polluted river has become a place where people and wildlife coexist. In 2019, Taehwagang National Garden was designated South Korea's second national garden. Restoring the river and forest has brought nature closer to everyday life in this industrial city.
At the nearby Migratory Bird Center, visitors can learn about the birds' behavior and habitats through exhibits and guided talks, and take in views from the observation deck. They can then enjoy a riverside walk amid rustling bamboo leaves and bird calls before watching the flocks at sunset.
Alexa, a Romanian exchange student who was 21 when she joined a familiarization tour in 2025, said, "I had never seen bamboo in person before. I had only seen the very small plants you can grow in an apartment, so this was an even more wonderful experience." She added, "Everyone was really kind."
Local residents help protect this landscape as birdwatching guides and nature interpreters, sharing stories about the birds and their community. They also participate in cleanups and work to address the challenges of living alongside wildlife while protecting its habitat. Their efforts show how people and wildlife can coexist in cities.
The best viewing season runs from December through February, with peak viewing within about 30 minutes of sunset. Timing and flock size vary with weather and bird movements. International visitors can arrive via Gimhae International Airport in Busan or take a KTX high-speed train from Seoul or other cities to Ulsan Station, then continue by local transport. Visitors should check the Migratory Bird Center's opening hours in advance.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Discover Winter Birdlife and Samho Bamboo Forest in Ulsan's Nam-gu
LeBleu® and KAMIYA Make Debut in Hong Kong, Drawing Widespread Industry Attention
HONG KONG, Nov. 13, 2026 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. (referred to as "Eyebright Medical", Stock Code: 688050.SH) completed its participation in the Hong Kong International Optical Fair 2026. Held from November 4 to 6, 2026, at the Hong Kong Convention and Exhibition Centre, the fair serves as a trade event for the optometry and eyewear industry, bringing together global buyers, eye care professionals, and brand representatives as a platform for technology exchange and international channel expansion.
At this year's exhibition, Eyebright Medical presented its vision care brand portfolio. Driven by the steady growth of the group's vision care sector, the dual brands LeBleu® and KAMIYA made a simultaneous appearance, showcasing Eyebright Medical's end-to-end R&D, manufacturing, and sales capabilities to partners across the Asia-Pacific region.
As Eyebright Medical's representative brand for contact lenses, LeBleu® incorporates the group's R&D capabilities in optical design and manufacturing. Backed by Eyebright Medical's R&D team of over 300 professionals and two self-owned, GMP-certified smart manufacturing bases — Jiangsu Tianyan Medical and Fujian Evercon, with a combined standardized R&D and production space of over 120,000 square meters. LeBleu® maintains end-to-end control over material R&D, optical design, manufacturing, and quality control, safeguarding product stability and wearing safety at the source.
LeBleu® presented several product series at the fair, including silicone hydrogel series, EDF aspheric daily disposable contact lenses, EDF+ high-order aspheric bi-weekly and half-year disposable contact lenses, and Toric color contact lenses. The product line incorporates Extended Depth of Focus (EDF) aspheric optical design alongside storage solution formulations containing Vitamin B12 and Hyaluronic Acid tailored for daily wear.
Sharing the spotlight was KAMIYA, an emerging color contact lens brand, which showcased its Spotlight Series Toric Color Contact Lenses in their Hong Kong debut. As Eyebright Medical's brand in the color lens segment, KAMIYA focuses on consumer preferences for fashion aesthetics and product value. Supported by Eyebright Medical's manufacturing infrastructure and digital quality control, KAMIYA maintains batch-level product traceability. Furthermore, utilizing high-speed AOI optical inspection systems and supply chain management, KAMIYA optimizes its cost structure to deliver accessible pricing.
The sample trial sessions during the exhibition generated strong interest. Channel partners from Hong Kong, Macao, and Southeast Asia inquired about product registration, packaging localization, and market promotion strategies, evaluating the commercial potential of color lens brands among young Asia-Pacific consumers.
Eyebright Medical's participation attracted media coverage and on-site interviews. Mr. Jia Baoshan, Deputy General Manager and Sales and Market Sales Director of Eyebright Medical Technology (Beijing) Co., Ltd., together with Ms. Zhou Yuxi, General Manager of Eyebright Medical's Hong Kong subsidiary, jointly participated in media interviews and shared the group's operational developments, outlining Eyebright Medical's international growth orientation and overall business structure. The organizer, Hong Kong Trade Development Council, also highlighted Eyebright Medical as an exhibitor case study across official event communications.
As an international hub connecting Mainland China with global markets, Hong Kong serves as a strategic node for Eyebright Medical's regional roadmap. Leveraging Hong Kong's business network and regulatory framework, Eyebright Medical's local team continues to advance international registration, academic engagement, and channel development across its vision care and ophthalmic device portfolios.
About Eyebright Medical Technology (Beijing) Co., Ltd.
Eyebright Medical Technology (Beijing) Co., Ltd. is listed on the STAR Market of the Shanghai Stock Exchange (Stock Abbreviation: Eyebright Medical, Stock Code: 688050.SH). Located in Zhongguancun Science Park, Beijing, it is a National High-Tech Enterprise and a recognized National "Little Giant" Enterprise specializing in niche markets. As an innovation-driven high-end medical device manufacturer with a global vision, Eyebright Medical has strategically laid out its presence across four high-potential sectors: ophthalmic surgical treatments, myopia management, consumer vision care, and sports medicine. Leveraging deep technical barriers and robust commercialization capabilities, the company is positioning itself among global medical technology leaders as a representative of China's intelligent manufacturing strength.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026
Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026
